IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
批准号:
6175954
负责人:
SALEH ADI
金额:
$11.64万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2002-06-30
关键词:
antisense nucleic acid athymic mouse binding proteins biological signal transduction biomarker cell differentiation cell growth regulation cyclin dependent kinase cyclins enzyme inhibitors gene expression growth factor receptors immunoprecipitation insulinlike growth factor muscle cells mutant myoblasts myogenesis northern blottings phosphorylation protein isoforms striated muscles transcription factor transfection western blottings
中文摘要
根据医生科学家奖(PSA),候选人,
赞助商,第一阶段咨询委员会,连同
儿科,已建成详细的2期5年
培训计划旨在为候选人提供一个密集的
培训和研究经验。第一阶段由11名毕业生组成
在5个部门开设司级课程,定期参加各种研讨会,
三个实验室轮换。 这种经验,仿照
研究生博士在生物医学科学的计划在大学的
加州、旧金山弗朗西斯科将满足
PSA。第二阶段是95- 100%的实验室研究,
的赞助商。
在第二阶段,候选人的研究工作将集中在
胰岛素样生长因子(IGFs)调节肌肉的机制
细胞分化这一目标将通过l)研究
IGF作用的潜在靶基因,这些基因在
分化过程,2)检查哪些IGF受体亚型介导
IGF的生肌作用; 3)探讨IGF的潜在作用
结合蛋白(BP)在调节IGF诱导的分化中的作用。期间
根据这一建议,将检验以下三个假设:l)IGFs
影响骨骼肌细胞生长或分化的决定
通过调节视网膜母细胞瘤蛋白(pRB)的磷酸化,
细胞周期机制的调节剂,当磷酸化时促进
生长,但当低磷酸化或未磷酸化时促进分化; 2)
IGF-II受体,独立于IGF-I受体,
肌生成;和3)IGFBPs,其可以增强或抑制IGF作用,
调节IGF诱导的肌细胞分化。测试这些
假设我们提出以下具体目标:l)检查效果
IGFs对pRB磷酸化的影响以及对主要的
细胞周期蛋白依赖性激酶(CDKs)及其调节亚基,细胞周期蛋白
以及调节pRB磷酸化的CDK抑制剂; 2)
IGF-I受体功能性失活
突变,以确定IGF-II受体是否可以信号肌细胞
独立于IGF-I受体的分化;和3)检查
肌细胞IGFBPs调节IGF诱导分化的能力
用反义cRNA抑制它们的表达。
这些研究应该通过以下方式提供对机制的进一步理解:
哪些IGFs调节肌肉细胞分化。研究链接
生长因子信号和细胞周期调节之间的联系
对于理解正常过程以及
异常增殖和分化。成功完成本
该计划将使候选人能够追求独立的职业生涯
研究内分泌功能的分子基础。
英文摘要
In accordance with the Physician Scientist Award (PSA), the candidate, the
sponsor, and the Phase I advisory committee, in conjunction with the
Department of Pediatrics, have constructed a detailed 2-phase 5-year
training program intended to provide the candidate with an intensive
training and research experience. Phase I consists of eleven graduate
division courses in 5 departments, regular attendance at various seminars,
and three laboratory rotations. This experience, modeled after the
graduate Ph.D. program in Biomedical Sciences at the University of
California, San Francisco, will fulfill the Phase I requirements of the
PSA. Phase Il is 95-lOO% laboratory research under the direct supervision
of the sponsor.
During phase II, the candidate's research effort will focus on the
mechanisms by which the insulin-like growth-factors (IGFs) regulate muscle
cell differentiation. This objective will be approached by l) studying
potential target genes of IGF action which play a role in the
differentiation process, 2) examining which IGF receptor subtypes mediate
the myogenic effect of IGFs, and 3) exploring the potential role of IGF
binding proteins (BPs) in modulating IGF-induced differentiation. During
this proposal, the following three hypotheses will be tested: l) that IGFs
influence the decision of skeletal muscle cells to grow or differentiate
by regulating the phosphorylation of retinoblastoma protein (pRB), a key
regulator of the cell cycle machinery, which when phosphorylated promotes
growth but when hypo- or unphosphorylated promotes differentiation; 2)
that IGF-II receptor, independently of IGF-I receptor, can signal
myogenesis; and 3) that IGFBPs, which may enhance or inhibit IGF action,
modulate IGF-induced differentiation in muscle cells. To test these
hypotheses we propose the following specific aims: l) Examine the effects
of IGFs on pRB phosphorylation and on the expression of the principal
cyclin-dependent kinases (CDKs) and their regulatory subunits, the cyclins
and the CDK inhibitors, which regulate pRB phosphorylation; 2)
Functionally inactivate the IGF-I receptor with a dominant negative
mutation to determine if the IGF-II receptor can signal muscle cell
differentiation independently of the IGF-I receptor; and 3) Examine the
ability of muscle cell IGFBPs to modulate IGF-induced differentiation by
inhibiting their expression with antisense cRNAs.
These studies should provide further understanding of the mechanisms by
which IGFs regulate muscle cell differentiation. Studying the links
between growth factor signaling and cell cycle regulation could have
general implications for understanding the processes of normal as well as
aberrant proliferation and differentiation. Successful completion of this
program will equip the candidate to pursue an independent career
investigating the molecular basis of endocrine function.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1210/endo.143.2.8648
发表时间:
2002-02
期刊:
Endocrinology
影响因子:
4.8
作者:
[S. Adi;Bassam Bin-Abbas;N. Wu;S. Rosenthal]
通讯作者:
S. Adi;Bassam Bin-Abbas;N. Wu;S. Rosenthal
DOI:
10.1002/1097-4644(20000915)78:4
发表时间:
2000-01-01
期刊:
JOURNAL OF CELLULAR BIOCHEMISTRY
影响因子:
4
作者:
[Adi, S, Cheng, ZQ, Rosenthal, SM]
通讯作者:
Rosenthal, SM
Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
Akt 磷酸化不足以促进胰岛素样生长因子刺激的肌细胞生成素表达,但必须伴有丝裂原激活蛋白激酶/细胞外信号调节激酶磷酸化的下调。
DOI:
10.1210/en.2004-0101
发表时间:
2004
期刊:
Endocrinology
影响因子:
4.8
作者:
[Tiffin,Nicki, Adi,Saleh, Stokoe,David, Wu,Nan-Yan, Rosenthal,StephenM]
通讯作者:
Rosenthal,StephenM
Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin.
LY294002 和 Wortmannin 不同程度地抑制生长因子刺激的 Akt 和 p70(S6K) 磷酸化。
DOI:
10.1210/endo.142.1.8051
发表时间:
2001
期刊:
Endocrinology
影响因子:
4.8
作者:
[Adi,S, Wu,NY, Rosenthal,SM]
通讯作者:
Rosenthal,SM
IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
-
批准号:2443765
-
项目类别:
-
资助金额:$7.52万
-
财政年份:1996
-
负责人:SALEH ADI
-
依托单位:
IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
-
批准号:2134359
-
项目类别:
-
资助金额:$7.48万
-
财政年份:1996
-
负责人:SALEH ADI
-
依托单位:
IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
-
批准号:2733813
-
项目类别:
-
资助金额:$10.97万
-
财政年份:1996
-
负责人:SALEH ADI
-
依托单位:
IGFS AND SKELETAL MUSCLE CELL DIFFERENTIATION
-
批准号:2904944
-
项目类别:
-
资助金额:$11.64万
-
财政年份:1996
-
负责人:SALEH ADI
-
依托单位:
海外基金